Ping An Biomedical Co., Ltd.
PASWNASDAQIndustrials● Active
$0.18
+$0.02(+11.80%)
Market Cap$3326098
P/E Ratio—
52W High$5.4
52W Low$0.121
Ping An Biomedical Co., Ltd.（PASW）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PASW · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $87.62M | $82.56M | $114.55M | $99.52M |
| Cost of Revenue | $82.21M | $78.32M | $100.40M | $85.25M |
| Gross Profit | $5.42M | $4.24M | $14.14M | $14.27M |
| Gross Margin %(computed) | 6.18% | 5.14% | 12.35% | 14.34% |
| Operating Expenses | ||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $4.54M | $2.88M | $2.76M | $2.93M |
| Total Operating Expenses | $5.42M | $3.63M | $3.33M | $6.00M |
| Operating Income | ($0.00M) | $0.61M | $10.82M | $8.27M |
| Operating Margin %(computed) | -0.00% | 0.74% | 9.44% | 8.31% |
| Interest Income | $0.00M | $0.16M | $0.04M | $0.00M |
| Interest Expense | $0.71M | $1.74M | $1.57M | $1.36M |
| Income Before Tax | ($0.68M) | $0.04M | $9.63M | $7.82M |
| Income Tax Expense | $0.60M | $1.04M | $2.40M | $2.61M |
| Net Income | ($1.28M) | ($0.99M) | $7.23M | $5.21M |
| Net Margin %(computed) | -1.47% | -1.20% | 6.31% | 5.24% |
| Per Share & EBITDA | ||||
| EPS (Basic) | $0.00 | $-0.05 | $0.35 | $0.38 |
| Wtd Avg Shares | 0.00M | 20.50M | 20.50M | 13.75M |
| EBITDA | $0.47M | $2.20M | $11.61M | $9.57M |
| EBITDA Margin %(computed) | 0.54% | 2.66% | 10.13% | 9.62% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · CNY · M
深入了解Ping An Biomedical Co., Ltd.
关于Ping An Biomedical Co., Ltd.（PASW）损益表
Ping An Biomedical Co., Ltd.（PASW）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，PASW实现营收$0.09B，毛利润$0.01B（毛利率6.18%），净利润($0.00B)（净利率-1.47%）。
常见问题
PASW · 4 问Ping An Biomedical Co., Ltd.（PASW）2024财年营收为$0.09B，同比up6.1%。
PASW revenuePASW salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08